Jefferies Group LLC Agios Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	BUY	$17.06 - $31.42 $58,311 - $107,393	3,418 Added 25.15%	17,010 $377,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $58,311 - $107,393	3,418 Added 25.15%	17,010 $377,000
Q1 2022 Sep 21, 2023	BUY	$26.68 - $34.81 $219,016 - $285,755	8,209 Added 152.5%	13,592 $395,000
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $362,634 - $473,137	13,592 New	13,592 $396,000
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $225,655 - $313,182	-5,383 Closed	0 $0
Q2 2021 Sep 21, 2023	SELL	$52.06 - $61.27 $143,112 - $168,431	-2,749 Reduced 33.8%	5,383 $296,000
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $280,238 - $329,816	5,383 New	5,383 $297,000
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $359,678 - $467,590	-8,132 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$33.21 - $46.54 $270,063 - $378,463	8,132 New	8,132 $352,000
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $91,194 - $127,798	-2,746 Reduced 25.24%	8,132 $352,000
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $986,362 - $1.63 Million	-29,122 Reduced 72.8%	10,878 $381,000
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $646,380 - $1.1 Million	20,507 Added 105.2%	40,000 $1.42 Million
Q4 2019 Feb 13, 2020	SELL	$30.08 - $50.59 $1.04 Million - $1.75 Million	-34,535 Reduced 63.92%	19,493 $931,000
Q3 2019 Nov 13, 2019	BUY	$32.4 - $49.58 $1.75 Million - $2.68 Million	54,028 New	54,028 $1.75 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.